▲ Peaking
Business
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
5sources
5articles
3velocity
+0%since first seen
2h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- Gilead's Trodelvy claims a pair of breast cancer approvals in the US FirstWord Pharma · 1d ago
- FDA backs Gilead’s Trodelvy for first-line, triple-negative breast cancer Endpoints News · 1d ago
- FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer Cure Today · 1d ago
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war Fierce Pharma · 1d ago
- New Drugs Are Replacing Chemo for Aggressive Breast Cancer WSJ · 1d ago
Related trends
▲ Peaking
Business
Polestar barred from US over the Chinese connected vehicle rule, a dangerous precedent
▲ Peaking
Business
How This New Fintech Billionaire Is Cashing In On Cross-Border Payments
▲ Peaking
Business
Microsoft Stock Is Having Its Worst Start to a Year Since the Dot-Com Crash
▲ Peaking
Business
Apple raises iPad and MacBook prices, blaming cost of chips amid AI boom
↓ Cooling
Business
OpenAI leans toward waiting until next year for IPO, NYT reports
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business